NYSE· Surgical & Medical Instruments & Apparatus· Inc. NJ· CIK 0000010795

BDX

BECTON DICKINSON & CO
$176.97 ▼ -0.62%
Prev close $178.07
Market cap$49.6B
ConsensusHold
12-mo target$195.67 (+10.6%)
▲ Bullish
Analyst conviction 6/10
Insider Selling Cluster (3 insiders)38 New Institutional Positions12 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on BDX right now — valuation, ownership and activity at a glance.
Market Cap
$49.6B
Cap Size
Large Cap
Analyst Consensus
Buy (57%)
Inst. Holders
50 funds
Inst. Value
$30.2B
Inst. Activity
38 buys / 12 sells
Insider Activity
$0.00 buy / $2.1M sell
Insider Net $
-$2.1M
Social Sentiment
43° Neutral
SEC Reports
9
Congressional
2 trades
Price chart 30d -5.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 other
BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
Generations of Utah employees have helped ensure the reliable supply of essential medical devices th
Sep 28, 2026 Insider
Feld Michael sold 76 shares
EVP, Chief Revenue Officer @ $183.70 ($14.0K)
Sep 2, 2026 Insider
Roque Vitor surrendered for taxes 190 shares
EVP & Chief Financial Officer
Aug 26, 2026 Insider
Feld Michael sold 165 shares
EVP, Chief Revenue Officer @ $188.49 ($31.1K)
Aug 15, 2026 SEC
BDX CEO Thomas Polen and EVP Roland Goette sold a combined $1.21M in open-market shares within a 7-day window. The CEO's
CLUSTER — Impact 2/10
Jul 22, 2026 SEC
BDX announced the retirement of EVP and segment President Mike Garrison, effective Oct. 2, 2026, after 20+ years. The Bi
8-K — Impact 2/10
Jul 6, 2026 SEC
Two BDX executives (EVP Garrison and EVP Feld) sold a combined $172K in shares over a 7-day window. The total value is n
CLUSTER — Impact 2/10
Jun 30, 2026 Inst.
NORGES BANK — NEW
4,169,523 shares ($631.0M)
Analyst ratings buy % +46.2%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Hold 57% rate it Buy or better · 21 analysts
Strong Buy 5 24% Buy 7 33% Hold 9 43% Sell 0 0% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Aug 31, 2026B of A SecuritiesMAINTAINNeutral 54%
Aug 13, 2026RBC CapitalMAINTAINSector Perform 55%
Aug 7, 2026CitigroupMAINTAINBuy 55%
Aug 7, 2026RBC CapitalMAINTAINSector Perform 55%
Aug 7, 2026Piper SandlerMAINTAINNeutral 54%
Aug 7, 2026Wells FargoMAINTAINEqual-Weight 54%
Aug 5, 2026TD CowenMAINTAINHold 56%
Jul 28, 2026UBSINITIATEBuy 55%
Jul 6, 2026Evercore ISI GroupMAINTAINOutperform 59%
May 11, 2026BarclaysMAINTAINOverweight 54%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20265790057%
Aug 1, 202655110048%
Jul 1, 202654120043%
Jun 1, 202654120043%
May 1, 202655110048%
Apr 1, 202654110045%
Mar 1, 202654110045%
Feb 1, 202643110039%
Price targets
Where 12 covering analysts think BDX trades over the next 12 months.
$195.67 +10.6% upside Buy
Current$176.97 Low$170.00 Median$197.50 High$225.00 12 analysts
$170.00$225.00
Analyst rating Buy· 2.1/5 as of Oct 2, 2026
Social media sentiment mood -16.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
43°
Neutral
BearishNeutralBullish
3 mentions 0 bullish 1 bearish 2 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
9 SEC filing reports analyzed · 0 bullish, 0 bearish, 1 mixed, 8 neutral · avg impact 3.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
other
BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
Generations of Utah employees have helped ensure the reliable supply of essential medical devices that clinicians use every day to care for patients a
Sep 21, 2026
other
Arthur Hu to Join BD as Chief Information and Digital Officer
FRANKLIN LAKES, N.J., Sept. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, toda
Sep 17, 2026
short_volume
Short Volume: BDX — 56.3% short (0.4M / 0.7M)
Short: 379,332 | Exempt: 34 | TRF Vol: 673,973 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Sep 16, 2026
short_volume
Short Volume: BDX — 65.7% short (0.3M / 0.5M)
Short: 347,986 | Exempt: 0 | TRF Vol: 529,629 | Short Ratio: 65.7% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: BDX — 65.7% short (0.5M / 0.8M)
Short: 502,247 | Exempt: 87 | TRF Vol: 764,728 | Short Ratio: 65.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$4.07$4.03–$4.112.7%+0.0%3↑ 7↓$5.1B11
Next Q$2.74$2.60–$3.01-5.8%+0.4%0↑ 7↓$4.6B9
Current FY$12.62$12.00–$12.70-12.3%+0.0%11↑ 0↓$19.3B14
Next FY$13.30$13.05–$14.055.4%+0.1%1↑ 9↓$19.7B14
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$4.065—
7d ago$4.065—
30d ago$4.065—
60d ago$4.090-0.024
90d ago$4.075-0.010
Institutional ownership
Which big funds own BDX (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $30.2B total value (191,645,409 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, MASSACHUSETTS. Net buying activity: 38 institutions added/increased vs 12 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.24,592,166$3.7B12.3%—
VANGUARD CAPITAL MANAGEMENT LLC17,987,834$2.7B9.0%—
MASSACHUSETTS FINANCIAL SERVICES CO /MA/8,650,967$2.5B8.2%—
STATE STREET CORP15,000,064$2.3B7.5%—
VANGUARD PORTFOLIO MANAGEMENT LLC14,974,136$2.3B7.5%—
First Eagle Investment Management, LLC13,815,335$2.1B6.9%—
Invesco Ltd.8,898,488$1.3B4.5%—
GEODE CAPITAL MANAGEMENT, LLC8,141,586$1.2B4.1%—
FRANKLIN RESOURCES INC7,011,592$1.1B3.5%—
WELLINGTON MANAGEMENT GROUP LLP6,357,986$962.2M3.2%—
Recent position changes
FundActionPrevCurrentChangeValue
NORGES BANKNEW—4,169,523—$631.0M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED1,002,3752,544,118+153.8%$385.0M
GOLDMAN SACHS GROUP INCTRIM2,482,1081,758,921-29.1%$266.2M
MACKENZIE FINANCIAL CORPDOUBLED41,2711,433,406+3373.2%$216.9M
BARCLAYS PLCADD793,9941,267,104+59.6%$191.8M
NORDEA INVESTMENT MANAGEMENT ABTRIM2,435,206789,490-67.6%$119.0M
STATE FARM MUTUAL AUTOMOBILE INSURANCE COADD508,249691,797+36.1%$104.7M
BANK OF MONTREAL /CAN/ADD398,623517,141+29.7%$78.3M
AMERIPRISE FINANCIAL INCADD271,657460,368+69.5%$69.7M
FMR LLCTRIM1,086,716459,929-57.7%$69.6M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 34 transactions. Net -$2.1M — $0.00 bought, $2.1M sold.
DateInsiderTitleTypeSharesPriceValue
Sep 28, 2026Feld MichaelEVP, Chief Revenue OfficerSELL76$183.70$14.0K
Sep 2, 2026Roque VitorEVP & Chief Financial OfficerTAX W/H190——
Aug 26, 2026Feld MichaelEVP, Chief Revenue OfficerSELL165$188.49$31.1K
Aug 20, 2026Feld MichaelEVP, Chief Revenue OfficerTAX W/H1,049——
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentEXERCISE43,278$167.25$7.2M
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentSELL4,152$185.00$768.1K
Aug 13, 2026Polen Thomas E JrChairman, CEO and PresidentD39,126$185.00$7.2M
Aug 11, 2026Goette RolandEVP and President, EMEASELL2,438$180.84$440.9K
Aug 6, 2026Byington Carrie LDirectorAWARD94$165.62$15.6K
Aug 6, 2026Huffines Robert LutherDirectorAWARD189$165.62$31.3K
Congressional trades
BDX trades disclosed by members of Congress, with disclosure delay.
2 members · 0 buys / 2 sells
DateMemberPartyChamberTypeAmountAssetDisclosed
May 21, 2026Thomas Kean JrRHOUSESELL$1,001 - $15,000Becton Dickinson and CoJun 19, 2026(30d)
Mar 17, 2026Kevin HernRHOUSESELL$15,001 - $50,000Becton Dickinson and CoApr 6, 2026(21d)
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BDX.
Shares short
11,316,237
Settlement Sep 15, 2026
Change vs prior
+6.0%
Semi-monthly cycle
Days to cover
7.2
At avg daily volume
Of shares outstanding
≈4.2%
Estimate — not % of float
All BDX filing & press-release reports (9)